
Ganapathy Krishnan
Examiner (ID: 6885, Phone: (571)272-0654 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1693, 1673 |
| Total Applications | 1710 |
| Issued Applications | 810 |
| Pending Applications | 207 |
| Abandoned Applications | 716 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17642052
[patent_doc_number] => 20220169790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => CARBOHYDRATE LIGANDS THAT BIND TO ANTIBODIES AGAINST GLYCOEPITOPES OF GLYCOSPHINGOLIPIDS
[patent_app_type] => utility
[patent_app_number] => 17/372422
[patent_app_country] => US
[patent_app_date] => 2021-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17372422
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/372422 | CARBOHYDRATE LIGANDS THAT BIND TO ANTIBODIES AGAINST GLYCOEPITOPES OF GLYCOSPHINGOLIPIDS | Jul 9, 2021 | Abandoned |
Array
(
[id] => 18567401
[patent_doc_number] => 20230257733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => METHOD FOR ISOLATING NUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 18/014960
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014960
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014960 | METHOD FOR ISOLATING NUCLEIC ACID | Jul 6, 2021 | Abandoned |
Array
(
[id] => 20171766
[patent_doc_number] => 12390486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Method for treating diastolic heart failure by inhibiting galectin-3
[patent_app_type] => utility
[patent_app_number] => 17/367957
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 1100
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367957
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/367957 | Method for treating diastolic heart failure by inhibiting galectin-3 | Jul 5, 2021 | Issued |
Array
(
[id] => 18871171
[patent_doc_number] => 11858957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Ectonucleotidase inhibitors and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/359990
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 46
[patent_no_of_words] => 67792
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 345
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359990
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/359990 | Ectonucleotidase inhibitors and methods of use thereof | Jun 27, 2021 | Issued |
Array
(
[id] => 18962865
[patent_doc_number] => 11896604
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Composition comprising HMSs/HMOs and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/353730
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9783
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353730
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/353730 | Composition comprising HMSs/HMOs and use thereof | Jun 20, 2021 | Issued |
Array
(
[id] => 18962866
[patent_doc_number] => 11896605
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Composition comprising HMSs/HMOs and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/353749
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8324
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353749
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/353749 | Composition comprising HMSs/HMOs and use thereof | Jun 20, 2021 | Issued |
Array
(
[id] => 18657766
[patent_doc_number] => 20230303721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => USE OF AN ACTIVATED PECTIN-CONTAINING CITRUS FIBER FOR PRODUCING PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 18/009296
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009296
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009296 | USE OF AN ACTIVATED PECTIN-CONTAINING CITRUS FIBER FOR PRODUCING PRODUCTS | Jun 9, 2021 | Pending |
Array
(
[id] => 18597326
[patent_doc_number] => 20230272121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => A WOOD-DERIVED CARBOHYDRATE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/009574
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009574
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009574 | A WOOD-DERIVED CARBOHYDRATE COMPOSITION | Jun 8, 2021 | Pending |
Array
(
[id] => 17140147
[patent_doc_number] => 20210308158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => SYNTHETIC COMPOSITION AND METHOD FOR TREATING IRRITABLE BOWEL SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/341039
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17341039
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/341039 | Synthetic composition and method for treating irritable bowel syndrome | Jun 6, 2021 | Issued |
Array
(
[id] => 17095308
[patent_doc_number] => 20210283099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => CDC7 KINASE INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/330957
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 325
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17330957
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/330957 | CDC7 kinase inhibitors and uses thereof | May 25, 2021 | Issued |
Array
(
[id] => 18451473
[patent_doc_number] => 20230192751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => METHOD FOR THE PREPARATION OF OLIGONUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 17/433460
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12628
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433460
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433460 | Method for the preparation of oligonucleotides | May 25, 2021 | Issued |
Array
(
[id] => 18581683
[patent_doc_number] => 20230263937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => BIOMATERIAL COMPRISING AT LEAST ONE ELASTOMERIC MATRIX AND A NON-SULFATED POLYSACCHARIDE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/997433
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997433
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997433 | BIOMATERIAL COMPRISING AT LEAST ONE ELASTOMERIC MATRIX AND A NON-SULFATED POLYSACCHARIDE AND USES THEREOF | May 19, 2021 | Pending |
Array
(
[id] => 17383874
[patent_doc_number] => 20220031726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML)
[patent_app_type] => utility
[patent_app_number] => 17/324248
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324248
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/324248 | NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML) | May 18, 2021 | Abandoned |
Array
(
[id] => 18559829
[patent_doc_number] => 11725064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Chimeric small molecules for the recruitment of antibodies to cancer cells
[patent_app_type] => utility
[patent_app_number] => 17/322124
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 26207
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 411
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322124
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/322124 | Chimeric small molecules for the recruitment of antibodies to cancer cells | May 16, 2021 | Issued |
Array
(
[id] => 18109557
[patent_doc_number] => 20230002437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/319224
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319224
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319224 | ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF | May 12, 2021 | Abandoned |
Array
(
[id] => 17213080
[patent_doc_number] => 20210346416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => Pharmaceutical Compositions and Methods for their Use in Antiviral Therapy
[patent_app_type] => utility
[patent_app_number] => 17/245841
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17245841
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/245841 | Pharmaceutical Compositions and Methods for their Use in Antiviral Therapy | Apr 29, 2021 | Abandoned |
Array
(
[id] => 18530241
[patent_doc_number] => 20230235311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => PROCESS FOR EXTRACTING DOUBLE-STRANDED DNA
[patent_app_type] => utility
[patent_app_number] => 17/920423
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920423
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/920423 | PROCESS FOR EXTRACTING DOUBLE-STRANDED DNA | Apr 22, 2021 | Abandoned |
Array
(
[id] => 20818695
[patent_doc_number] => 12674157
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-07
[patent_title] => Transport media for clinical specimen collection and molecular diagnostic applications and methods of production and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/907202
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2842
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907202
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907202 | Transport media for clinical specimen collection and molecular diagnostic applications and methods of production and use thereof | Apr 19, 2021 | Issued |
Array
(
[id] => 18707549
[patent_doc_number] => 20230330125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => ORAL COMPOSITION COMPRISING S-ADENOSYL METHIONINE AND A PROBIOTIC AND ITS USE FOR TREATING AND/OR PREVENTING MOOD DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/918915
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918915
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918915 | ORAL COMPOSITION COMPRISING S-ADENOSYL METHIONINE AND A PROBIOTIC AND ITS USE FOR TREATING AND/OR PREVENTING MOOD DISORDERS | Apr 19, 2021 | Pending |
Array
(
[id] => 17426787
[patent_doc_number] => 20220054495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/234744
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234744
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/234744 | Compositions and methods for enhanced delivery of antiviral agents | Apr 18, 2021 | Issued |